Fidelity Investments’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-339
| Closed | -$10K | – | 4489 |
|
|
2018
Q4 | $10K | Buy |
+339
| New | +$9.63K | ﹤0.01% | 3061 |
|
|
2017
Q4 | – | Sell |
-533,477
| Closed | -$14.7M | – | 2741 |
|
|
2017
Q3 | $14.7M | Sell |
533,477
-9,326,801
| -95% | -$249M | ﹤0.01% | 1804 |
|
|
2017
Q2 | $247M | Buy |
9,860,278
+2,378,077
| +32% | +$58.9M | 0.03% | 592 |
|
|
2017
Q1 | $201M | Buy |
7,482,201
+137,399
| +2% | +$3.8M | 0.03% | 692 |
|
|
2016
Q4 | $193M | Sell |
7,344,802
-1,926,505
| -21% | -$47.6M | 0.03% | 688 |
|
|
2016
Q3 | $232M | Buy |
9,271,307
+1,733,496
| +23% | +$40.4M | 0.03% | 606 |
|
|
2016
Q2 | $163M | Buy |
7,537,811
+3,040,601
| +68% | +$54.2M | 0.02% | 753 |
|
|
2016
Q1 | $67.4M | Buy |
4,497,210
+1,176,627
| +35% | +$19.7M | 0.01% | 1131 |
|
|
2015
Q4 | $72.8M | Buy |
3,320,583
+710,283
| +27% | +$13.2M | 0.01% | 1100 |
|
|
2015
Q3 | $41.2M | Sell |
2,610,300
-177,540
| -6% | -$2.85M | 0.01% | 1325 |
|
|
2015
Q2 | $39.8M | Sell |
2,787,840
-1,413,913
| -34% | -$23.9M | 0.01% | 1438 |
|
|
2015
Q1 | $72.7M | Sell |
4,201,753
-2,012,447
| -32% | -$35.6M | 0.01% | 1176 |
|
|
2014
Q4 | $111M | Buy |
6,214,200
+1,494,500
| +32% | +$24.1M | 0.01% | 958 |
|
|
2014
Q3 | $62M | Buy |
4,719,700
+622,229
| +15% | +$8.38M | 0.01% | 1199 |
|
|
2014
Q2 | $58.9M | Buy |
4,097,471
+1,451,971
| +55% | +$19M | 0.01% | 1273 |
|
|
2014
Q1 | $33.7M | Buy |
2,645,500
+1,300,010
| +97% | +$17M | ﹤0.01% | 1511 |
|
|
2013
Q4 | $13.5M | Buy |
1,345,490
+161,700
| +14% | +$1.84M | ﹤0.01% | 1867 |
|
|
2013
Q3 | $15.6M | Sell |
1,183,790
-329,110
| -22% | -$4.32M | ﹤0.01% | 1787 |
|
|
2013
Q2 | $21.6M | Buy |
+1,512,900
| New | +$19M | ﹤0.01% | 1634 |
|
Other funds holding NXTM
Fidelity Investments's NXTM Position: Q1 2019 in Review
Fidelity Investments sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 339 shares — an estimated $10K sold.
Fidelity Investments first reported a position in NXTM in Q2 2013 and held it in 19 quarters. The position peaked at $247M in Q2 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- Fidelity Investments reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- Fidelity Investments sold 339 NxStage Medical Inc. shares in Q1 2019, an estimated $10K.
- Fidelity Investments first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 19 quarters.
- Fidelity Investments's NxStage Medical Inc. position peaked at $247M in Q2 2017.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on Fidelity Investments's 13F filing for Q1 2019, filed 13 May 2019.